Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-ketamine versus propofol-sufentanil for procedural sedation and analgesia in children with hematologic malignancies
IRCT20170809035601N9Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hematopoietic malignancies and acute lymphoblastic leukemia (ALL) comparing Propofol + ketamine with Propofol + sufentanil (2 arms). Primary endpoints: Sedation level and Analgesia. Started Apr 2017; status: completed.
02
Drugs
propofolketaminesufentanil
03
Conditions
hematopoietic malignanciesacute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20170809035601N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170809035601N9.